Failed in phase 2
Lipid / vascular (statins etc.): reduce relapses and new lesions in early MS (CIS or RIS)
early MS (CIS or RIS) · Lipid / vascular (statins etc.)
Controlled phase 2 trials did not meet their main goal for this group.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 82
How the verdict was reached
Negative in phase 2
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| STAYCIS | Phase 2 | 82 | 2005 | Missed its main goal | Counted |
Counted: 1. Will count later: 0. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Failed in phase 2
Related hypotheses
Assembled by software from public sources.